Beijing Cygenta Biotech Co., Ltd.
PrivateLast Round
Series C
Extension
Apr 19, 2023
Total Funding Raised
$116.79M
Company Overview
Beijing Cygenta Biotech Co., Ltd. is a biotechnology company that provides contract development and manufacturing organization (CDMO) services for gene and cell therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Compliance, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beijing Cygenta Biotech Co., Ltd. Comparables
Compare Beijing Cygenta Biotech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| uBriGene Biosciences | 88% | |
| OBiO Technology | 83% | |
| Porton Pharma Solutions Ltd. | 79% |
Beijing Cygenta Biotech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Apr 19, 2023 | ||||
| Series C | Sep 26, 2022 | ||||
| Series B | Sep 16, 2021 | ||||
| Series A | Dec 15, 2020 | ||||
| Early Funding | Oct 21, 2019 |
Beijing Cygenta Biotech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IDG Capital | Series C, Series B |
| 中信金石投资有限公司 | Series C |
| Beijing Fangfu Venture Capital Management | Series C Extension, Series A, Series B, Series C |
| Yuanchuang Duoying Investment Group | Series C |
| Huagai Capital | Series B, Series C, Series A |
| Addor Capital | Series B |
| Chiron Ventures | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2023
$22M round led by Guotai Junan Innovation Investment.
- Sep 26, 2022
$43M round led by CLSA Capital Partners and 中信金石投资有限公司.
Beijing Cygenta Biotech Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Beijing Cygenta Biotech Co., Ltd.'s valuation, stock price, and market status.
Is Beijing Cygenta Biotech Co., Ltd. a public or private company?
Beijing Cygenta Biotech Co., Ltd. is a private company.
What is the current stock price of Beijing Cygenta Biotech Co., Ltd.?
Beijing Cygenta Biotech Co., Ltd. is a private company with no public stock price. Caplight tracks Beijing Cygenta Biotech Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Beijing Cygenta Biotech Co., Ltd. worth (valuation)?
Valuation information for Beijing Cygenta Biotech Co., Ltd. is not publicly available.
Can I buy Beijing Cygenta Biotech Co., Ltd. stock?
Beijing Cygenta Biotech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Beijing Cygenta Biotech Co., Ltd.'s last funding round?
Beijing Cygenta Biotech Co., Ltd.'s most recent funding round was Series C Extension on April 19, 2023.
Who are the main investors in Beijing Cygenta Biotech Co., Ltd.?
Key investors in Beijing Cygenta Biotech Co., Ltd. include IDG Capital, 中信金石投资有限公司, Huagai Capital, Addor Capital, 国泰君安创新投资有限公司.
Will Beijing Cygenta Biotech Co., Ltd. IPO soon?
No public IPO plans have been announced for Beijing Cygenta Biotech Co., Ltd..
How can I track Beijing Cygenta Biotech Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Beijing Cygenta Biotech Co., Ltd.'s secondary market activity and sign up for updates.